Sabra Health Care REIT Beheer

Beheer criteriumcontroles 4/4

De CEO Sabra Health Care REIT is Rick Matros, benoemd in May2010, heeft een ambtstermijn van 14.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.22M, bestaande uit 11.3% salaris en 88.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.92% van de aandelen van het bedrijf, ter waarde $ 40.05M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.9 jaar en 6.5 jaar.

Belangrijke informatie

Rick Matros

Algemeen directeur

US$8.2m

Totale compensatie

Percentage CEO-salaris	11.3%
Dienstverband CEO	14.5yrs
Eigendom CEO	0.9%
Management gemiddelde ambtstermijn	3.9yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Recent updates

Here's Why We Think Sabra Health Care REIT, Inc.'s (NASDAQ:SBRA) CEO Compensation Looks Fair for the time being

Jun 10

Sabra Health Care stock climbs 2.7% after Stifel turns bullish

May 10

Sabra Health Care REIT, Inc. Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

May 09

Sabra Health Care declares $0.30 dividend

May 05

Don't Ignore The Fact That This Insider Just Sold Some Shares In Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Mar 12

Declining Stock and Decent Financials: Is The Market Wrong About Sabra Health Care REIT, Inc. (NASDAQ:SBRA)?

Mar 02

Sabra Health Care declares $0.30 dividend

Feb 02

Have Insiders Been Selling Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares?

Jan 26

Analyse CEO-vergoeding

Hoe is Rick Matros's beloning veranderd ten opzichte van Sabra Health Care REIT's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$97m
Jun 30 2024	n/a	n/a	US$52m
Mar 31 2024	n/a	n/a	US$49m
Dec 31 2023	US$8m	US$925k	US$14m
Sep 30 2023	n/a	n/a	-US$88m
Jun 30 2023	n/a	n/a	-US$123m
Mar 31 2023	n/a	n/a	-US$128m
Dec 31 2022	US$7m	US$925k	-US$78m
Sep 30 2022	n/a	n/a	-US$17m
Jun 30 2022	n/a	n/a	US$43m
Mar 31 2022	n/a	n/a	-US$106m
Dec 31 2021	US$6m	US$925k	-US$113m
Sep 30 2021	n/a	n/a	-US$52m
Jun 30 2021	n/a	n/a	-US$26m
Mar 31 2021	n/a	n/a	US$137m
Dec 31 2020	US$5m	US$925k	US$138m
Sep 30 2020	n/a	n/a	US$141m
Jun 30 2020	n/a	n/a	US$128m
Mar 31 2020	n/a	n/a	US$182m
Dec 31 2019	US$6m	US$900k	US$69m
Sep 30 2019	n/a	n/a	US$10m
Jun 30 2019	n/a	n/a	US$22m
Mar 31 2019	n/a	n/a	US$132m
Dec 31 2018	US$5m	US$850k	US$269m
Sep 30 2018	n/a	n/a	US$390m
Jun 30 2018	n/a	n/a	US$367m
Mar 31 2018	n/a	n/a	US$192m
Dec 31 2017	US$5m	US$850k	US$148m

Compensatie versus markt: De totale vergoeding ($USD 8.22M ) Rick } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.56M ).

Compensatie versus inkomsten: De vergoeding van Rick is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Rick Matros (70 yo)

14.5yrs

Tenure

US$8,219,499

Compensatie

Mr. Richard K. Matros, also known as Rick, is Director of INSPIRIS, Inc. He is Chairman of Sabra Health Care REIT, Inc. from November 04, 2010 and Director, President & CEO since May 2010. From 1998 until...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Matros	Chairman	14.5yrs	US$8.22m	0.92% $ 40.1m
Michael Costa	Executive VP	2.8yrs	US$2.95m	0.043% $ 1.9m
Talya Nevo-Hacohen	Executive VP	14yrs	US$3.57m	0.32% $ 14.0m
Jessica Flores	Executive VP	less than a year	geen gegevens	0.025% $ 1.1m
Peter Nyland	Executive Vice President of Asset Management	11.8yrs	geen gegevens	geen gegevens
Darrin Smith	Executive Vice President of Investments	4.7yrs	geen gegevens	geen gegevens
Lukas Hartwich	Senior Vice President of Finance	3.1yrs	geen gegevens	geen gegevens
Eliza Gozar	Senior Vice President of Investments	3.1yrs	geen gegevens	geen gegevens

3.9yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SBRA wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Matros	Chairman	14.5yrs	US$8.22m	0.92% $ 40.1m
Michael Foster	Lead Independent Director	14yrs	US$251.89k	0.027% $ 1.2m
Jeffrey Malehorn	Independent Director	7.3yrs	US$236.89k	0.018% $ 781.4k
Lynne Katzmann	Independent Director	5.7yrs	US$234.30k	0.0052% $ 224.7k
Craig Barbarosh	Independent Director	14yrs	US$248.39k	0.035% $ 1.5m
Clifton Porter	Independent Director	3.9yrs	US$220.39k	0.00022% $ 9.6k
Ann Kono	Independent Director	3.9yrs	US$218.39k	0% $ 0
Katie Cusack	Independent Director	3.8yrs	US$216.39k	0.0021% $ 91.9k

6.5yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SBRA wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

Sabra Health Care REIT Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 13, 2024

Sabra Health Care REIT, Inc. Announces Executive Changes

Insufficient new directors

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 14, 2022

Sabra Health Care REIT, Inc. Announces Resignation of Raymond J. Lewis as Board of Directors

Consultant recently sold US$1.5m worth of stock

Recent updates

Third quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

Sabra Health Care REIT, Inc. Updates Earnings Guidance for the Year 2024

New minor risk - Shareholder dilution

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Health Care REIT, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. announces Quarterly dividend, payable on August 30, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Health Care REIT, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Sabra Health Care REIT: 2 Catalysts That Should Ignite Solid Growth

First quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sabra Healthcare REIT: An Attractive Value Proposition With Moderate Leverage

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 13, 2024

Sabra Health Care REIT, Inc. to Report Q1, 2024 Results on May 08, 2024

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on February 29, 2024

Full year 2023 earnings released: EPS: US$0.059 (vs US$0.34 loss in FY 2022)

Sabra Health Care REIT: A Risk Worth Taking

Third quarter dividend of US$0.30 announced

Sabra Health Care REIT, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Sabra Health Care REIT, Inc. Announces Executive Changes

Insufficient new directors

Third quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care REIT, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Sabra Health Care Reit, Inc. Declares A Quarterly Cash Dividend, Payable on August 31, 2023

Second quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care REIT, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Upcoming dividend of US$0.30 per share at 11% yield

Sabra Health Care Reit, Inc. Reports Impairment Charges for Three Months Ended March 31, 2023

First quarter 2023 earnings: EPS misses analyst expectations

Sabra Health Care Reit, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Ensign Group, Inc. (NasdaqGS:ENSG) completed the acquisition of Twenty skilled nursing operations of Sabra Health Care in the state of California.

Sabra Health Care REIT, Inc. to Report Q4, 2022 Results on Feb 21, 2023

The Ensign Group, Inc. (NasdaqGS : ENSG) entered into an agreement to acquire Twenty skilled nursing operations in the state of California from Sabra Health Care REIT, Inc. (NasdaqGS : SBRA).

Third quarter 2022 earnings: Revenues miss analyst expectations

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on November 30, 2022

Sabra Health Care REIT, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Sabra Health Care REIT Pays A Good Dividend

Upcoming dividend of US$0.30 per share

Sabra Health Care declares $0.30 dividend

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Sabra Health Care REIT, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Sabra Health Care REIT, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Sabra Health Care: 8.45% Dividend Yield With Limited Downside Risk

The Ensign Group, Inc. (NasdaqGS:ENSG) acquired the Real Estate and Operations of McKinney Healthcare and Rehabilitation Center from Sabra Health Care REIT, Inc. (NasdaqGS:SBRA).

Sabra: Strong, Steady Dividend, But Also Needs Capacity Building

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) completed the acquisition of Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on May 31, 2022

Sabra Health Care REIT, Inc., Annual General Meeting, Jun 14, 2022

Sabra Health Care REIT, Inc. to Report Q1, 2022 Results on May 04, 2022

Sabra: FFO Likely To Drop 10% In 2022

An unknown buyer acquired Four Skilled Nursing/Transitional Care Facilities, Two Senior Housing Communities and Two Hospitals from Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) for $85.9 million.

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Sabra Health Care REIT, Inc. Announces Resignation of Raymond J. Lewis as Board of Directors

Sienna Senior Living Inc. (TSX:SIA) and Sabra Health Care REIT, Inc. (NasdaqGS:SBRA) entered into an agreement to acquire Portfolio of Eleven Private-Pay Retirement Residences in Ontario and Saskatchewan from Extendicare Inc. (TSX:EXE) for approximately CAD 310 million.

Sabra Health Care REIT, Inc. Declares Quarterly Cash Dividend, Payable on February 28, 2022

Consultant recently sold US$1.5m worth of stock

Sabra Health Care: A Monster Yield At A Good Price

Sabra Health Care: This 8.8% Yield REIT Is Trading At A Discount

Sabra Health Care REIT: Stresses Pick Up In Q3

Upcoming dividend of US$0.30 per share

Third quarter 2021 earnings released: EPS US$0.046 (vs US$0.18 in 3Q 2020)

Reasons That Make Sabra A Great Fit To Be Acquired By Welltower

Upcoming dividend of US$0.30 per share

Second quarter 2021 earnings released: US$0.61 loss per share (vs US$0.14 profit in 2Q 2020)